This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Winter, R. N. Articles by Kyprianou, N. Search for Related Content PubMed PubMed Citation Articles by Winter, R. N. Articles by Kyprianou, N.

Loss of Caspase-1 and Caspase-3 Protein Expression in Human Prostate Cancer¹

Departments of Biochemistry and Molecular Biology [R. N. W., N. K.], Urologic Surgery [A. K., N. K.], and Pathology [A. B.], University of Maryland School of Medicine, Baltimore, Maryland 21201

Activation of the caspase cascade is involved in the execution of apoptosis in a variety of cellular systems. Recent studies demonstrated that caspase-1 activation was required for human prostate cancer cells to undergo apoptosis in response to transforming growth factor-ß (Y. Guo and N. Kyprianou, Cancer Res., 59: 1366–1371, 1999). In the present study, to identify the significance of caspases in prostate cancer progression, we examined the expression of three key caspases, caspase-1, caspase-3, and caspase-9, in normal and malignant human prostates. Caspase-1, -3, and -9 expression was examined at the mRNA and the protein level in a series of human normal and malignant prostate specimens. No significant differences were observed in the mRNA expression in prostatic tumors relative to the normal gland for any of the three caspases. Immunohistochemical analysis revealed that the pattern of protein expression and distribution was uniformly homogeneous in the normal prostate, with the epithelial cells exhibiting a diffuse cytoplasmic staining for caspase-1 and caspase-3. Significantly, the majority of primary prostate cancer specimens (80%) had total lack of caspase-1 immunoreactivity, whereas the remaining showed a significantly reduced expression compared with the normal prostate (P < 0.05). Caspase-3 expression was also reduced in moderately and poorly differentiated prostatic tumors compared with well-differentiated prostate adenocarcinomas and the normal prostate (P < 0.05). No significant correlation was found between the apoptotic index or Gleason grade and the pattern of caspase protein expression in the primary prostatic tumors analyzed. Western blot analysis revealed constitutive expression of the proenzyme forms of caspase-1, -3, and -9 in the human prostate cancer cell lines PC-3, DU-145, TSU-Pr1m and LNCaP, but caspase-1 expression was low in the less tumorigenic cell lines, DU-145 and LNCaP. These findings implicate the loss of caspase-1 protein as a potential step in the loss of apoptotic control during prostate tumorigenesis. This study suggests that the pattern of caspase-1 and -3 expression in prostatic tumors may have prognostic significance in disease progression.

This article has been cited by other articles:

				A. Sakai, Y. Sugawara, T. Kuroishi, T. Sasano, and S. Sugawara Identification of IL-18 and Th17 Cells in Salivary Glands of Patients with Sjogren's Syndrome, and Amplification of IL-17-Mediated Secretion of Inflammatory Cytokines from Salivary Gland Cells by IL-18 J. Immunol., August 15, 2008; 181(4): 2898 - 2906. [Abstract] [Full Text] [PDF]

				R. L. Thangapazham, N. V. Rajeshkumar, A. Sharma, J. Warren, A. K. Singh, J. A. Ives, J. P. Gaddipati, R. K. Maheshwari, and W. B. Jonas Effect of Homeopathic Treatment on Gene Expression in Copenhagen Rat Tumor Tissues Integr Cancer Ther, December 1, 2006; 5(4): 350 - 355. [Abstract] [PDF]

				S. T. Page, D. W. Lin, E. A. Mostaghel, D. L. Hess, L. D. True, J. K. Amory, P. S. Nelson, A. M. Matsumoto, and W. J. Bremner Persistent Intraprostatic Androgen Concentrations after Medical Castration in Healthy Men J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3850 - 3856. [Abstract] [Full Text] [PDF]

				R. Arriazu, J. M. Pozuelo, N. Henriques-Gil, T. Perucho, R. Martin, R. Rodriguez, and L. Santamaria Immunohistochemical Study of Cell Proliferation, Bcl-2, p53, and Caspase-3 Expression on Preneoplastic Changes Induced by Cadmium and Zinc Chloride in the Ventral Rat Prostate J. Histochem. Cytochem., September 1, 2006; 54(9): 981 - 990. [Abstract] [Full Text] [PDF]

				S. Thomas, S. Chigurupati, M. Anbalagan, and G. Shah Calcitonin Increases Tumorigenicity of Prostate Cancer Cells: Evidence for the Role of Protein Kinase A and Urokinase-Type Plasminogen Receptor Mol. Endocrinol., August 1, 2006; 20(8): 1894 - 1911. [Abstract] [Full Text] [PDF]

				Q. Feng, P. Li, C. Salamanca, D. Huntsman, P. C.K. Leung, and N. Auersperg Caspase-1{alpha} Is Down-regulated in Human Ovarian Cancer Cells and the Overexpression of Caspase-1{alpha} Induces Apoptosis Cancer Res., October 1, 2005; 65(19): 8591 - 8596. [Abstract] [Full Text] [PDF]

				A. Bozec, A. Ruffion, M. Decaussin, J. Andre, M. Devonec, M. Benahmed, and C. Mauduit Activation of Caspases-3, -6, and -9 during Finasteride Treatment of Benign Prostatic Hyperplasia J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 17 - 25. [Abstract] [Full Text] [PDF]

				A. Caporali, P. Davalli, S. Astancolle, D. D'Arca, M. Brausi, S. Bettuzzi, and A. Corti The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression Carcinogenesis, November 1, 2004; 25(11): 2217 - 2224. [Abstract] [Full Text] [PDF]

				K. Zu and C. Ip Synergy between Selenium and Vitamin E in Apoptosis Induction Is Associated with Activation of Distinctive Initiator Caspases in Human Prostate Cancer Cells Cancer Res., October 15, 2003; 63(20): 6988 - 6995. [Abstract] [Full Text] [PDF]

				Y. Mori, F. Sato, F. M. Selaru, A. Olaru, K. Perry, M. C. Kimos, G. Tamura, N. Matsubara, S. Wang, Y. Xu, et al. Instabilotyping Reveals Unique Mutational Spectra in Microsatellite-Unstable Gastric Cancers Cancer Res., July 1, 2002; 62(13): 3641 - 3645. [Abstract] [Full Text] [PDF]

				M. G. Sanna, J. d. S. Correia, O. Ducrey, J. Lee, K. Nomoto, N. Schrantz, Q. L. Deveraux, and R. J. Ulevitch IAP Suppression of Apoptosis Involves Distinct Mechanisms: the TAK1/JNK1 Signaling Cascade and Caspase Inhibition Mol. Cell. Biol., March 15, 2002; 22(6): 1754 - 1766. [Abstract] [Full Text] [PDF]